Lessac-Madsen Resonant Voice Therapy
BehavioralPatients receive 8 sessions of therapy over a course of 4 weeks, with one double session per week.
NCT Number: NCT00222937
The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in seeing if Lessac-Madsen Resonant Voice Therapy (LMRVT) and Casper-Based Confidential Flow Therapy (CBCFT) are equally effective at improving vocal functioning in teachers with phonotrauma, as assessed by the Voice Handicap Index (VHI).
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 3
Massachusetts Eye & Ear Infirmary, Voice and Speech Laboratory, Boston, Massachusetts, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive 8 sessions of therapy over a course of 4 weeks, with one double session per week.
Patients receive 8 sessions of therapy over a course of 4 weeks, with one double session per week.
Time frame: one year
Time frame: one year
Time frame: one year
Time frame: one year
Time frame: one year
Time frame: one year
University of Pittsburgh
Other
Efficacy of Voice Therapy for Phonotrauma in Teachers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05625191
Phonotrauma
Dallas, Texas, United States
View Trial DetailsNCT05158166
Adductor Spasmodic Dysphonia, Dysphonia
San Francisco, California, United States
View Trial DetailsNCT04710862
Laryngeal Diseases, Muscle Tension Dysphonia
Syracuse, New York, United States
View Trial DetailsNCT07062302
Laryngeal Diseases, Nervous System Diseases
Shatin, N.T., Hong Kong
View Trial Details